SK

Sunita Kiran Bhusare

Active Director Director DIN 07702652
DIN 07702652 First appointment Mar 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value •••• Premium profile

About Sunita Kiran Bhusare

Data last updated:

Sunita Kiran Bhusare is a Director at Regenhealth Lifesciences Private Limited (since 2017). The company operates in Trading. Regenhealth Lifesciences Private Limited reported revenue of ₹38.3 Lakh (FY 2025).

DIN 07702652
Primary Designation Director
Industry Trading
First Appointment 01 Mar 2017
Oldest Company Age 9 yrs
Largest company Regenhealth Lifesciences Private Limited · ₹38.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20172017₹38.3 Lakh (FY 2025)Active

Board colleagues of Sunita Kiran Bhusare

Directorship timeline

Open interactive timeline →
Regenhealth Lifesciences Private Limited
Premium access

Shareholding and investment profile for Sunita Kiran Bhusare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Kiran Bhusare

Sunita Kiran Bhusare currently holds 1 directorship: Regenhealth Lifesciences Private Limited (Director, since 01 Mar 2017, revenue ₹38.3 Lakh (FY 2025)).

Sunita Kiran Bhusare was first appointed on 01 Mar 2017 as Director at Regenhealth Lifesciences Private Limited.

The current boards of Sunita Kiran Bhusare's companies include Kiran Manikrao Bhusare (Regenhealth Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available